FHI Clinical to support ACTT remdesivir trial for COVID-19 July 23, 2020 Auto Bot Clinical Development 0 The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study
